
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 March 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 3MB, 220 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“Statins and the risk of idiopathic venous thromboembolism”, Br J Clin Pharmacol, vol. 53, pp. 101-5, 2002.
, “Statins and the risk of pneumonia: a population-based, nested case-control study”, Pharmacotherapy, vol. 27, pp. 325-32, 2007.
, “A study of the relation of exposure to quinolones and suicidal behaviour”, Br J Clin Pharmacol, vol. 45, pp. 77-81, 1998.
, “Sudden unexplained death among subjects with refractory epilepsy”, Epilepsia, vol. 37, pp. 931-5, 1996.
, “Tamoxifen and risk of idiopathic venous thromboembolism”, Br J Clin Pharmacol, vol. 45, pp. 608-12, 1998.
, “Terfenadine and risk of acute liver disease”, Br J Clin Pharmacol, vol. 46, pp. 251-3, 1998.
, “Time trends in eating disorder incidence”, Br J Psychiatry, vol. 186, pp. 132-5, 2005.
, “Urinary tract infections and estrogen use in older women”, J Am Geriatr Soc, vol. 40, pp. 817-20, 1992.
, “Use of dexfenfluramine, fenfluramine and phentermine and the risk of stroke”, Br J Clin Pharmacol, vol. 47, pp. 565-9, 1999.
, “Use of nonsteroidal anti-inflammatory drugs and the risk of first-time acute myocardial infarction”, Br J Clin Pharmacol, vol. 54, pp. 327-32, 2002.
, “Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction”, Br J Clin Pharmacol, vol. 52, pp. 179-84, 2001.
, “Use of thiazolidinediones and fracture risk”, Arch Intern Med, vol. 168, pp. 820-5, 2008.
, “Validation of information recorded on general practitioner based computerised data resource in the United Kingdom”, Bmj, vol. 302, pp. 766-8, 1991.
, “Validity of the general practice research database”, Pharmacotherapy, vol. 23, pp. 686-9, 2003.
,